If you would like to send us an article, contact Margaret Stacey
Natural Shrimp supported the trial by making three trips to Japan.
Natural Shrimp, Inc. Completes Successful Trial in Japan
(UNITED STATES, 4/22/2024)
Natural Shrimp, Incorporated (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first seafood-focused commercially operational RAS (Recirculating Aquaculture System), announced it has completed at the end of February 2024 a successful 6-month trial in Japan with the Company's patented Electrocoagulation (EC) and Hydrogas™ technologies.
Pacific white shrimp.
One week after arriving in Japan, the Natural Shrimp and Hydrenesis' team, with the assistance of the Japanese team, installed and began operating the Equipment at the Japanese shrimp research facility.
The trial compared a tank treated by the EC and Hydrogas™ with a tank treated by a traditional biofilter. Throughout the 6-month trial, the EC effectively removed the ammonia from the water. In addition, the shrimp growth rate increased during the presence of Hydrogas when compared to the shrimp growth rate in the tank treated only by the biofilter.
Natural Shrimp supported the trial by making three (3) trips to Japan during the Trial Period and continued to actively participate in the Trial by remote access to the Equipment between trips. However, after initial instruction by the NSI team, the Japanese team was able to independently operate the EC and Hydrogas equipment on their own.
Tom Untermeyer.
The Japanese team performed extensive testing of the Equipment that included, among other things, collecting data under varying conditions by testing different flow rates, ammonia levels, and amperage levels. Based on the empirical results demonstrated by the Equipment during the Trial, Natural Shrimp looks to either joint venture, License or form a business combination in Japan.
Tom Untermeyer, Natural Shrimp Chief Technology Officer said, "I very much enjoyed working with the team in Japan during the installation and operation of our Equipment in the Japanese shrimp research facility. The Japanese quickly learned how to operate the EC and Hydrogas equipment and shared with us the data that they collected during the trial.
The Japanese market is uniquely set up for the NSI technology based on its current shrimp import conditions and a robust consumption of shrimp as a primary protein source. I am excited to see where this will lead us in the future with the hope of helping them and others develop successful shrimp production systems using our technologies."
Natural Shrimp has developed patented proprietary technology to produce fresh, gourmet-grade shrimp without the use of antibiotics, probiotics or toxic chemicals.
About Natural Shrimp
Natural Shrimp, Incorporated is a publicly traded aquaculture Company, headquartered in Dallas, with production facilities located near San Antonio, Texas, and Webster City, Iowa.
The Company has developed the first commercially viable system for growing shrimp in enclosed salt-water systems using patented technology to produce fresh, naturally grown shrimp, without the use of antibiotics or toxic chemicals. Natural Shrimp systems can be located anywhere in the world to produce gourmet-grade Pacific white shrimp.
Japan’s Marine Product Imports Exceed Domestic Production Japan
The following is an excerpt from an article published by nippon.com:
Japan’s fishing industry is not the force that it once was, and in 2022 the country imported marine products worth ¥2 tr...
Fish face vast decline if emissions are not reduced Worldwide
The following is an excerpt from an article published by Dialogue Earth:
Failing to keep warming to below 3C could mean a 30% decline in catchable fish in many countries, huge study suggests
Gl...
Korean Market Situation for Shrimp and Cuttlefish South Korea
As of June 2024, the volume of frozen whiteleg shrimp imported into the country recorded 235 tons, a 72% decrease compared to the same period last year, and this figure is a significant decrease from ...
(UNITED STATES, 4/22/2024)
Print
